These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2801715)

  • 1. Multidisciplinary program for detecting and evaluating adverse drug reactions.
    Keith MR; Bellanger-McCleery RA; Fuchs JE
    Am J Hosp Pharm; 1989 Sep; 46(9):1809-12. PubMed ID: 2801715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Program coordinated by a drug information service to improve adverse drug reaction reporting in a hospital.
    Michel DJ; Knodel LC
    Am J Hosp Pharm; 1986 Sep; 43(9):2202-5. PubMed ID: 3766573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a database computer program to identify trends in reporting of adverse drug reactions.
    Johnston PE; Morrow JD; Branch RA
    Am J Hosp Pharm; 1990 Jun; 47(6):1321-7. PubMed ID: 2368725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of standardized screening procedures to identify adverse drug reactions.
    Koch KE
    Am J Hosp Pharm; 1990 Jun; 47(6):1314-20. PubMed ID: 2368724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW; Scollins MJ; Gay CA; Harry DJ; Giannuzzi DF
    Am J Hosp Pharm; 1990 Jun; 47(6):1327-33. PubMed ID: 2368726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. System for voluntary reporting of adverse drug reactions in a university hospital.
    Vorce-West TE; Barstow L; Butcher B
    Am J Hosp Pharm; 1989 Nov; 46(11):2300-3. PubMed ID: 2589347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary adverse drug reaction surveillance program.
    Prosser TR; Kamysz PL
    Am J Hosp Pharm; 1990 Jun; 47(6):1334-9. PubMed ID: 2368727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a videotape on adverse drug reactions.
    Morgan SA; Frank JT
    Am J Hosp Pharm; 1990 Jun; 47(6):1340-2. PubMed ID: 1695062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reaction program using pharmacist and nurse monitors.
    Miwa LJ; Randall RJ
    Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous quality assurance monitoring by staff pharmacists.
    Spradling GF
    Hosp Pharm; 1990 Nov; 25(11):1021-4, 1027. PubMed ID: 10108872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-managed monitoring of adverse reactions to contrast media.
    Damiani DR; Swanson DP
    Am J Hosp Pharm; 1994 Feb; 51(3):358-63. PubMed ID: 8160688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital.
    Murphy BM; Frigo LC
    Hosp Pharm; 1993 Dec; 28(12):1199-204, 1240. PubMed ID: 10130617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
    Saltiel E; Johnson E; Shane R
    Hosp Formul; 1995 Apr; 30(4):226-8, 231-2. PubMed ID: 10141866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the development of a multidisciplinary adverse drug reaction committee.
    Etzel JV; Brocavich JM; Rousseau M
    Hosp Pharm; 1995 Dec; 30(12):1083-7. PubMed ID: 10153655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Documenting concurrent clinical pharmacy interventions.
    Haslett TM; Kay BG; Weissfellner H
    Hosp Pharm; 1990 Apr; 25(4):351-5, 359. PubMed ID: 10104389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Canadian pharmacist involvement in adverse drug reaction reporting.
    Taras-Zasowski KM; Einarson TR
    Can J Hosp Pharm; 1989 Jun; 42(3):105-8, 133. PubMed ID: 10318271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting adverse drug reactions on a geriatric ward: a pilot project.
    Somers A; Petrovic M; Robays H; Bogaert M
    Eur J Clin Pharmacol; 2003 Feb; 58(10):707-14. PubMed ID: 12610749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.